Published April, 2011
By Jonathan Waxman
Publisher: Cambridge University Press
Series: Cancer: Clinical Science in Practice
Rating:
Availability: Available

This 1996 volume from the series Cancer: Clinical Science in Practice considers the many aspects of hormonally dependent cancer, including the molecular basis for the autocrine and paracrine regulation of cancer, molecular strategies for cancer detection, preventive strategies in limiting the epidemic of hormonally related cancers, and treatment approaches.

---

Published November, 2010
By Karol Sikora, A. G. Dalgleish, M. J. Browning, A.G. Dalgleish and M.J. Browning
Publisher: Cambridge University Press
Series: Cancer: Clinical Science in Practice
Rating:
Availability: Available

This 1996 volume reviewed advances in the field of human tumour immunology, particularly in relation to the potential for immune intervention in preventing or treating tumours. The contributors survey advances in the understanding of the relationship between the cancer cell and the immune response at the time of publication.

---

Published February, 2007
By Karol Sikora, Brian E. Huber, Ian Magrath and Ian T. Magrath
Publisher: Cambridge University Press
Series: Cancer: Clinical Science in Practice
Rating:
Availability: Available

Drawing on laboratory studies and clinical trials, including the work of the contributors themselves, this timely volume in the series Cancer: Clinical Science in Practice reviews progress in the fast-evolving field of gene therapy in oncology and looks forward to future developments.

---

Published January, 2007
By Herbert M. Pinedo, Giuseppe Giaccone, Karol Sikora and H.M. Pinedo
Publisher: Cambridge University Press
Series: Cancer: Clinical Science in Practice
Rating:
Availability: Available

Reviews the mechanisms and clinical implications of drug resistance in cancer, considered to be the most significant obstacle to the cure of cancer today. Topics covered include multiple drug resistance and its reversal, topoisomerase drugs, apoptosis, dose intensity and escalation, gene therapy and haematopoietic support.

---